Wegovy cost with insurance
Wegovy's maker lets one savings form serve both sides of the question. With commercial coverage, Novo's card brings a fill toward $25; without coverage, or choosing not to use it, the same form leads to NovoCare's self-pay price instead.
How much is Wegovy with insurance?
With a plan that covers Wegovy, the Wegovy savings card brings a fill to as little as $25. It takes off at most $100 a month, so $25 is what you pay only when your plan's own copay is $125 or less; above that, you pay the difference. Novo's savings form also takes the uninsured and anyone choosing not to use their insurance, but what it gives them is NovoCare's self-pay price, not a copay discount. Paying cash, Wegovy is $349 a month once titrated, read from its own published page on 2026-09-11.
What the card leaves you paying
“As little as $25 a month” is the headline. The cap behind it decides whether that is your price: the card pays the part of your copay above $25, up to $100 a month, so the higher your plan places Wegovy on its formulary, the less of the headline you see.
| Your plan's copay for a month | The card pays | You pay |
|---|---|---|
| $50 | $25 | $25 |
| $125 | $100 | $25 |
| $250 | $100 | $150 |
| $500 | $100 | $400 |
Arithmetic on the card's published cap, not a quote: your plan's copay for Wegovy is on its formulary.
The terms: Savings are capped at $100 a month, so it only reaches $25 if your plan already covers most of the cost.
Read from the Wegovy savings card page on 2026-09-05. Run your own copay through the calculator →
Three uses, and only one of them is weight
Wegovy's label carries three indications: reducing the risk of heart attack, stroke and cardiovascular death in adults with established cardiovascular disease and either obesity or overweight; long-term weight reduction in adults, and in adolescents from 12 with obesity; and noncirrhotic MASH with moderate to advanced liver fibrosis, stages F2 to F3, under accelerated approval.
An employer plan that excludes weight-loss drugs has excluded one of those three. For someone with a prior heart attack, stroke or peripheral arterial disease, the request is for cardiovascular risk reduction and is judged on that; for someone whose liver fibrosis is staged F2 to F3, it is a liver request. Neither is a way round the exclusion. Each needs its own diagnosis in the chart.
How many employers cover it for weight
- 16% of firms with 200 to 999 workers
- 30% of firms with 1,000 to 4,999 workers
- 43% of firms with 5,000 or more workers
Firms offering health benefits whose largest plan covers GLP-1s used primarily for weight loss, in 2025. Among the largest that is up from 28% a year earlier, and 34% of covering firms require a dietitian, case manager, therapist or lifestyle program first. 2025 Employer Health Benefits Survey: summary of findings, KFF.
Indications read from FDA prescribing information for WEGOVY, via DailyMed.
If your plan says no
Find out which refusal it is first. A prior-authorization denial means the plan covers Wegovy and says this request did not meet its criteria; that has a deadline and an appeal. An exclusion means the benefit was never bought, so no appeal reaches it, and the question is for whoever chose the plan.
A standard prior authorization has to be decided within 15 days of the request, extendable once by 15; an urgent one within 72 hours. You have at least 180 days from a denial to appeal inside the plan, then four months from the final denial to ask for independent external review, unless the plan is grandfathered. 29 CFR 2560.503-1; 45 CFR 147.136
What a Wegovy request has to show → At a denial, the appeal letter builder runs in your browser and sends nothing.
Every route, and what it costs
| Your situation | What you pay |
|---|---|
| A plan that covers it, with the card | As little as $25 a month, within the caps above |
| A plan that excludes it | Novo's savings form also takes the uninsured and anyone choosing not to use their insurance, but what it gives them is NovoCare's self-pay price, not a copay discount. Self-pay: $349 a month once titrated |
| Medicare, Medicaid or TRICARE | The card is barred — federal anti-kickback rules. Your plan's own rules decide instead. |
Cash price checked 2026-09-11.
Your insurer, and the other routes
Wegovy with insurance, answered
- How much is Wegovy with insurance?
- With a plan that covers it, as little as $25 on the maker's card, which takes off at most $100 a month. A copay above $125 leaves you paying the difference — $400 becomes $300. If your plan does not cover Wegovy, the self-pay price is $349 a month once titrated.
- Is Wegovy covered by insurance?
- For weight, only where your employer included weight-loss drugs: in KFF's 2025 survey the plans covering GLP-1s for weight loss were those of 16% of firms with 200 to 999 workers, 30% of firms with 1,000 to 4,999 workers, 43% of firms with 5,000 or more workers. Wegovy prescribed to reduce cardiovascular risk in established heart disease is a different use, and a plan that excludes weight loss can still cover it for that.
- Can I use the Wegovy savings offer with Medicare or Medicaid?
- Not as a copay card: Novo excludes government beneficiaries from it, as every maker does under federal anti-kickback rules. Novo's page does say government-insured patients may use the program if they pay for the fill themselves, outside their insurance — which gets them the self-pay price, not a discount on a copay.
- What is the difference between the Wegovy copay card and the first-fill offer?
- The copay card lowers what a covered prescription costs you, down to its $25 floor within its monthly cap. The first-fill offer is a self-pay price for new patients' first two fills at the two lowest doses. One needs coverage and the other assumes none; both are on the Wegovy savings page with their terms and end dates.